Meera Niranjan Khadilkar1, K Keshava Pai2, Thripthi Rai3, Vijendra Shenoy3, Deviprasad Dosemane3, Sushmitha Kabekkodu3. 1. Department of Otorhinolaryngology and Head and Neck Surgery, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, Mangalore, 575001, India. meera.khadilkar@manipal.edu. 2. Department of Psychiatry, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, Mangalore, 575001, India. 3. Department of Otorhinolaryngology and Head and Neck Surgery, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, Mangalore, 575001, India.
Abstract
PURPOSE: Patients with malignancy quite often suffer from physical as well as psychological symptoms due to the shattering diagnosis, and prolonged, incapacitating management. The frequency of the depressive disorder in malignancy is around 8-40%. The present study aims at analysing the socio-demographic profile and magnitude of depressive disorders in patients with malignancy. METHODS: A cross-sectional study was conducted in malignancy patients attending an Ear Nose Throat department using the PHQ-9 questionnaire. RESULTS: Total PHQ-9 score ranged from 0 to 19; the mean score was 8.46. Major depressive disorder was seen in 4 (8%) cases, while other depressive disorder occurred in 22 (44%) cases. Mild severity of symptoms was noted in 15 (30%) of the patients. High statistical significance was noted between PHQ-9 score for MDD and other depressive disorder (p value < 0.001). CONCLUSION: The profile of depressive disorders in malignancy varies; PHQ-9 can be used as a good tool for early detection.
PURPOSE:Patients with malignancy quite often suffer from physical as well as psychological symptoms due to the shattering diagnosis, and prolonged, incapacitating management. The frequency of the depressive disorder in malignancy is around 8-40%. The present study aims at analysing the socio-demographic profile and magnitude of depressive disorders in patients with malignancy. METHODS: A cross-sectional study was conducted in malignancypatients attending an Ear Nose Throat department using the PHQ-9 questionnaire. RESULTS: Total PHQ-9 score ranged from 0 to 19; the mean score was 8.46. Major depressive disorder was seen in 4 (8%) cases, while other depressive disorder occurred in 22 (44%) cases. Mild severity of symptoms was noted in 15 (30%) of the patients. High statistical significance was noted between PHQ-9 score for MDD and other depressive disorder (p value < 0.001). CONCLUSION: The profile of depressive disorders in malignancy varies; PHQ-9 can be used as a good tool for early detection.
Authors: Tim J Hartung; Michael Friedrich; Christoffer Johansen; Hans-Ulrich Wittchen; Herman Faller; Uwe Koch; Elmar Brähler; Martin Härter; Monika Keller; Holger Schulz; Karl Wegscheider; Joachim Weis; Anja Mehnert Journal: Cancer Date: 2017-06-27 Impact factor: 6.860
Authors: Rebecca M Saracino; Mark I Weinberger; Andrew J Roth; Arti Hurria; Christian J Nelson Journal: Psychooncology Date: 2016-05-16 Impact factor: 3.894
Authors: Brittany Barber; Jace Dergousoff; Linda Slater; Jeffrey Harris; Daniel O'Connell; Hamdy El-Hakim; Vincent L Biron; Nicholas Mitchell; Hadi Seikaly Journal: JAMA Otolaryngol Head Neck Surg Date: 2016-03 Impact factor: 6.223